Breaking News
Windows 10 is DEAD in 2025? -- Here's How I Run It SAFELY Forever (No Updates)
GENIUS ACT TRIGGERED: The Biggest BANK RUN in History is COMING – Prepare NOW
European Billionaires Funneled $2 Billion into NGO Network to Fund Anti-Trump Protest Machine
Japan Confirms Over 600,000 Citizens Killed by COVID mRNA 'Vaccines'
Top Tech News
HUGE 32kWh LiFePO4 DIY Battery w/ 628Ah Cells! 90 Minute Build
What Has Bitcoin Become 17 Years After Satoshi Nakamoto Published The Whitepaper?
Japan just injected artificial blood into a human. No blood type needed. No refrigeration.
The 6 Best LLM Tools To Run Models Locally
Testing My First Sodium-Ion Solar Battery
A man once paralyzed from the waist down now stands on his own, not with machines or wires,...
Review: Thumb-sized thermal camera turns your phone into a smart tool
Army To Bring Nuclear Microreactors To Its Bases By 2028
Nissan Says It's On Track For Solid-State Batteries That Double EV Range By 2028
Carbon based computers that run on iron
Anti-Aging Researcher David Sinclair Takes Metformin, NMN, NAD for Longevity
In 2013, GlaxoSmithKline shutdown Sirtris (David Sinclair's company) about five years after spending $720 million to buy Sirtris.
David A. Sinclair, Ph.D., A.O. is a Professor in the Department of Genetics and co-Director of the Paul F. Glenn Center for the Biology of Aging at Harvard Medical School. Dr. Sinclair is co-founder of several biotechnology companies (Sirtris, Ovascience, Genocea, Cohbar, MetroBiotech, ArcBio, Liberty Biosecurity) and is on the boards of several others. He is also co-founder and co-chief editor of the journal Aging.
Life Biosciences was co-founded in 2017 by David A. Sinclair, PhD, AO, a professor in the Department of Genetics at Harvard Medical School, and Tristan Edwards, an investment professional who developed its innovative company structure.